Innovation at IGTP

The Can Ruti Campus is a multidisciplinary space, where several biomedical institutions that produce leading scientific research at both national and international level are located. The synergies they produce have created a unique ecosystem for the development of innovation projects.

On campus the different institutions promote translational medicine and professionals carry out research, foster innovative ideas and generate knowledge designed to meet unmet clinical needs. This atmosphere has led the Innovation Unit of the Germans Trias i Pujol Research Institute to create a technology transfer model based on:

  • Promotion of a culture of innovation among researchers that encourages motivating work environments, favors the generation of ideas, creativity, collaborations between professionals and an entrepreneurial vocation.
  • The provision of a program to support projects with transfer potential, which allows their valorization and facilitates their transfer and an economic return for the Institute.
  • The promotion of an open innovation model that complements the skills and technologies developed at the IGTP and establishes collaborations with other centers, companies and service providers
  • Consolidation of the leadership of the Institute in research and innovation and promotion of its international projection.

The annual indicators of the Institute show the growth of innovative proposals in recent years, proposals that are meeting some of the great challenges of R+D+i. With 9 spin-offs, 35 active patent families and 19 licensing agreements, we are positioned as a center of reference and excellence in innovation in health.

The innovation model we use at the IGTP aims to catalyze and energize the projects that need to be commercialized. Through our program we support researchers in matters of validation of opportunities, funding, intellectual protection or transfer strategy.

Since April 2023, we are an EATRIS Expert Centre, enabling us to provide services related to innovation management and health technology assessment through this network.

INNOVATION POLICY AND STRATEGY

Innovation at IGTP in figures

  • 68

    Incubated projects

  • 20

    Technology offer portfolio

  • 189

    Active patents

  • 35

    Active patent families

  • 19

    License agreements

  • 9

    Active spin-offs

Latest innovation news

Innomed visits IDNEO to learn about its capabilities in device development and digital technologies

The Innomed community visited IDNEO to learn about its capabilities in device development, digital technologies and MedTech solutions. The visit aimed to identify opportunities for collaboration between research teams and industry to advance healthcare innovation projects.

IGTP project receives €49,000 from CaixaImpulse to advance a precision cell therapy for multiple sclerosis

A project led by Federico Fondelli, researcher at the IGTP, has been selected in the 2026 CaixaImpulse Health Innovation call promoted by the "la Caixa" Foundation. The project will receive €49,000 to advance the development of a new cell therapy strategy aimed at specifically restoring the immune system's tolerance to myelin in people with multiple sclerosis.

+ News